Substance P is a tachykinin that enhances pathways of inflammation. Leukocytes at sites of intestinal inflammation make substance P. This study explored the role of interleukin-12 (IL-12), IL-23, and the regulatory cytokines IL-10 and transforming growth factor  (TGF-) in controlling leukocyte substance P production. In murine schistosomiasis, it was found that IL-12 and IL-23 drive substance P gene expression and peptide synthesis in murine splenic T cells and macrophages, respectively. Cytokine induction of substance P synthesis both in T cells and in macrophages depends on intracellular NF-B activation and is Stat4 independent. IL-10 inhibits T-cell substance P production, while TGF- blocks macrophage substance P expression. Intestinal macrophages also produce substance P, subject mostly to IL-23 and TGF- regulation. Hemokinin is another tachykinin with homology to substance P. Macrophages and T cells make hemokinin, but hemokinin production is not subject to IL-12 or IL-23 regulation.Substance P (SP), an 11-amino-acid peptide, and its natural ligand the neurokinin 1 receptor (NK-1R) help regulate immune balance at mucosal surfaces and at other sites of chronic inflammation. SP derives from preprotachykinin A mRNA (PPT A), which is a product of the Tac 1 gene.SP is an important part of the Th1 pathways of inflammation, and its lack negatively affects the outcome of various infectious diseases. The granulomas of murine schistosomiasis display a completely functional SP immunoregulatory circuit (25). Experiments have shown that these granulomas are not normal if the mouse has a defect in the SP receptor (4). Thus, we study schistosomiasis to better understand how SP and its receptor function in inflammation. In the granulomas of murine schistosomiasis, SP made locally within the granulomas helps govern gamma interferon (IFN-␥) release (4). SP interacts with the SP receptor (NK-1R) expressed on the Th1 cells.The importance of SP in controlling the Th1 response also is evident in a murine model of salmonellosis, where treatment with an NK-1R antagonist diminishes the mucosal IFN-␥ response, leaving the animals more susceptible to the infection (13). SP also has a proinflammatory role in Th1 murine models of inflammatory bowel disease (9,23,27). Clostridium difficile can produce toxins in the intestines that induce colitis. NK1Rs, and by inference SP, help mediate C. difficile toxin-induced mucosal injury (6). Thus, the study of the SP immunoregulatory circuit in murine schistosomiasis has implications for other disease states too.Human, mouse, and rat leukocytes produce SP. It can come from T cells (14), macrophages (11,17,22), dendritic cells (15), or eosinophils (28). Lamina propria mononuclear cells (LPMC) isolated from the acutely injured murine intestines produce SP (5). Macrophages in the lamina propria of wild-type (WT) mice and interleukin-10 (IL-10)-deficient mice with colitis can make SP (1). T lymphocytes and macrophages make SP in both Th1-and Th2-type granulomas (1). Lipopolysaccharide may induce...